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I appreciate the opportunity to provide my perspective on three interrelated topics relevant to the NABC 6 open forum on agricultural biotechnology 
and public good. These interrelated topics are 1. a self-generated hierarchical 
structure of public good; 2. selected examples of the status of current and next- 
generation agricultural biotechnology products and processes in the areas of 
food, crop production, energy, materials and human health with a listing of 
their public good; and 3. the need for initiatives such as the Alternative Agri-
cultural Research and Commercialization Agency (AARC) to facilitate tech-
nology development and commercialization so that agricultural biotechnol-
ogy products and processes will be available in the marketplace and thereby 
provide public good. Public good is the common denominator of these prod-
ucts. It is not only important but imperative in today’s post-cold war, tight 
budget environment that the public good of new products and processes be 
communicated to the public. The public is more interested in the public good 
of products and processes than they are in the sophisticated tools and intellec-
tual approaches that are used to generate the products and processes.
The public good story for those agricultural products and processes that 
are approved and marketed and the projection of the public good for next gen-
eration products and processes is a very positive one and, to date, has been in-
adequately communicated. The public good is a story of improved food safety 
and food quality, lower cost food, improved human health, new jobs, products 
made from materials produced (and in many cases also processed) in prima-
rily rural communities, decreased subsidies, decreased environmental prob-
lems, and increased sustainability. As change occurs due to new agricultural 
biotechnology products and processes, society at large should benefit; at the 
same time, certain subsets of society that fail to or are unable to take advan-
tage of the new opportunities will be disadvantaged. This will be no different 
for agricultural biotechnology than for any other technological change or 
change in governmental policy, trade or finance. In fact, the extensive dis-
cussion of these products and processes prior to their market introduction is
providing more advance information than has occurred for almost any other 
technological change. Without question, there are more advance indications 
of the impact of biotechnology products or processes than there are for gov-
ernment policy, trade and financial change, to list a few that can also have ma-
jor impacts on producers. It is hoped that the following perspective will help to 
stimulate productive discussion on agricultural biotechnology and public good.
WHAT IS PUBLIC GOOD?
If we are to address the impact of current and next generation agricultural bio-
technology products and processes on public good, we need a description of 
public good. There is no broadly accepted description of public good. Any de-
scription is influenced by the viewpoint of the individual or the organization 
that produces it. The structure I will provide is based on a hierarchy of relative 
importance based on my personal viewpoint. This viewpoint has evolved from 
a career in science that has been almost exclusively in the private sector and, 
until the last few years, in the for-profit private sector. I also recognize the im-
portance of the viewpoints of others, including consumers. Robert Nicholas’ 
and my recognition of the need for a vehicle through which all viewpoints 
could be expressed in an open forum led us in 1987 to found the National Agri-
cultural Biotechnology Council (NABC). I have had the benefit of participat-
ing in the open discussion at all five previous NABC annual meetings. These 
and other dialogues have sensitized me to a diversity of issues and viewpoints 
regarding agricultural biotechnology. Based on these inputs and some recent 
conversations with individuals outside the science community, I have gener-
ated a hierarchical structure of public good (Figure 1). My prioritization of 
the structure is based mainly on a U.S. national perspective.
FIGURE 1
r HIERARCHICAL STRUCTURE 
OF PUBLIC GOOD
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Freedom  of  Choice
In my list, freedom of choice is the most important public good. Let me relate 
freedom of choice to agricultural biotechnology. One should have the oppor-
tunity to choose, if one wishes to do so. If one wishes to choose, one has a re-
sponsibility to become informed so that a decision is an informed one. Use-
ful information must be provided so that one can make such an informed choice. 
Words like “transgenic” or “genetically engineered” may be useful, at best, to 
a scientist. In my view, such words are of no use for decision-making by a con-
sumer. On the other hand, highly information-rich designations such as Flavr 
Savr™ tomatoes are very useful to me as a consumer wishing to make an in-
formed choice.
We need to provide information-rich designations throughout the pro-
duction and distribution system. As, for example, Monsanto’s proposed des-
ignation of “Roundup Ready™” to grain farmers for crops tolerant to the her-
bicide Roundup®. The name Prosilac™, used by Monsanto for their bovine 
somatotropin (bST) product, is information-rich for dairy farmers. How-
ever, there has been a failure to provide information to the consumers of milk 
that will enable them to make an informed choice to purchase, or not to pur-
chase, milk produced from cows treated with bST. I appreciate that there is 
no chemically analyzable difference between milk from cows treated with bST 
and those not treated with bST. Some consumers, though, are understand-
ably expressing concern because they have been denied this right to choose. 
Personally, I would appreciate the ability to exercise the right to choose in 
this case. I would like to be able to choose milk from bST-treated cows be-
cause it is my understanding that average or above average dairy farm man-
agement is required for successful use of bST. As someone who grew up on a 
dairy farm, I would like my milk to come from the best managed dairy farms. 
In the same way product identification for marketing provides information 
for choice by the producer/user, such as the dairy or grain farmer in the above 
examples, there should be information for choice by the ultimate consumer, 
especially when a significant proportion of consumers indicate the desire 
to have such information.
Knowledge
Knowledge is probably the second most important public good. To exercise 
freedom of choice, one must be informed, i.e., have knowledge about, the ob-
ject of that choice. Many organizations are involved in the knowledge area. 
The public trust varies with respect to information provided by different or-
ganizations (i.e., perceived acceptable knowledge provided). In January of 
1994 Thomas J. Hoban IV conducted a survey for the Grocery Manufacturers 
of America to assess the amount of trust that individuals had in sources of in-
formation on the safety of bST. This survey was conducted in the month pre-
ceding the first commercial sale of bST in the U.S. Trust was highest (80+ 
percent) for information provided by organizations such as the American
Medical Association (AMA), the National Institutes of Health (NIH), the Food 
and Drug Administration (FDA) and the American Dietetic Association (ADA). 
Trust was lowest for grocery stores, activist groups and chefs.
Human  Health
In my list, human health is the third most important public good. Within the 
human health area I include food and medical aspects of human health such as 
food adequacy and security, food safety, nutritional quality, food preference 
characteristics, food variety, food cost, wellness, diagnostics, therapeutics, 
vaccines and prostheses. Current and next generation agricultural biotech-
nology products from new foods to food-vaccines are expected to impact 
broadly on human health.
Economics
The next public good is the economic area. There are several economic fac-
tors from the public good perspective. A major one is new jobs in both urban 
and rural locations. In addition, there are issues of production, productivity, 
value-added, proprietariness, competitiveness, community development, 
imports, exports, subsidies and taxes. Agricultural biotechnology products 
and processes can have significant impacts on many of these economic fac-
tors. For example, it is critical that the U.S. reduce its need for agricultural 
subsidies and that we create jobs in rural locations. Agricultural biotechnol-
ogy products, in the longer term, have major potential in both these areas.
Many of the public good issues of economics are first and foremost na-
tional issues. In the U.S. there are about 90 million acres of excess or unused 
agricultural land that could be used for production. Our productivity is in-
creasing two to two and a half percent annually. There is also a continuing 
decline in grain exports from 150 million tons exported in the late 1970s to 
only 90 million tons in the early 1990s, and this continuing decline in exports 
will expand substantially the number of excess arable acres. The availability 
of this excess acreage capacity and the power of agricultural biotechnology 
provide the potential for major economic public good, especially in rural 
communities.
Most people agree that a product or process should be economically com-
petitive to remain in the market. A growing segment of our society is sympa-
thetic to so-called “green” products and processes. However, “green” prod-
uct or process alternatives that involve a significant additional cost over tra-
ditional products without other advantages probably will not survive in the 
marketplace, or if they do, will only have a very small market share. There 
may be indirect production costs for which we need to develop systems to in-
corporate these costs in the selling price of a product. These indirect costs are 
most relevant to the next public good areas of environment and sustainability.
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Environment
As the more primary and traditional public good needs of human health and 
economics are met, society begins to address additional public good issues. 
Environment, in my view, is the next public good issue. The environmentally 
related actions of many developed countries in the last quarter of the 20th cen-
tury document the public good acceptance of environment as a timely con-
cern. There are many environmental issues including erosion, salinization, 
desertification, soil and water contamination, air quality (ozone [OJ, nitro-
gen oxides [NOJ, sulfur dioxide [S02], volatile organic chemicals [VOC]), 
stratospheric ozone/UVB, wetland preservation, greenhouse gases, forestry, 
etc. There are existing or projected examples where agricultural biotechnol-
ogy products or processes favorably impact the environment.
Sustainability
The next emerging public good issue is sustainability. We are still in the pro-
cess of defining sustainability. Almost all agree that use of renewable versus 
nonrenewable sources and resource conservation fall under sustainability. In 
addition, some believe that sustainability requires self-sufficiency at the local 
level. Agricultural biotechnology products and processes are clearly relevant 
to the use of renewable sources.
Global Interdependence
Increasingly, we recognize that there is, indeed, global interdependence, and 
it is in the national interest to address issues at a global level. These global 
public good issues include humanitarian ones, environmental ones such as 
global environmental change and pollution, and economic ones such as the 
global marketplace, proprietariness, sources and rights to genetic materials, 
technology access, trade and tariffs. It is clear that agricultural biotechnology 
products and processes will impact and be impacted by the above global pub-
lic good issues.
Other Public Goods
There are many other public good issues that apply to limited areas or subsets 
of people in contrast to the above global and national ones. Some of these 
public good issues may be identified under the composite public good area 
of pride. Pride occurs at many levels: national, community, organizational, 
ethnic and cultural. There are religious beliefs—these are considered as a pub-
lic good by those people who so believe. There are those who believe that “how 
things were” is a public good. I refer to these as the “way things were” myths. 
One of these is the family-farm myth. I grew up on a family farm. I often have 
fond recollections of that family farm, but then I recall only too clearly the 
reality of the family farm of the 1940s. The reality was that intellectually
unchallenging, repetitive physical labor dominated the family farm of the 
1940s. There were, though, significant opportunities for entrepreneurial 
family farmers in the 1940s as, I believe, there are in the 1990s.
The hierarchical structure of public good presented in Table 1 and de-
scribed above is a self-generated list. You may strongly agree; you may 
strongly disagree. The list is a starting point that I will use in a summary of 
selected current and next generation agricultural biotechnology products and 
processes.
SELECTED EXAMPLES OF CURRENT AND NEXT GENERATION 
AGRICULTURAL BIOTECHNOLOGY PRODUCTS AND PROCESSES 
The number of current agricultural biotechnology products and processes in 
the marketplace has doubled within the last year. The premier agricultural 
biotechnology product to date is chymosin for cheesemaking which was ap-
proved by the Food and Drug Administration (FDA) over four years ago and 
now has more than a 60 percent share of the market. If you have eaten cheese 
regularly during the last four years, it is almost certain that you have eaten 
cheese made with highly pure chymosin produced by transgenic microorgan-
isms, rather than using the highly impure chymosin obtained traditionally 
from stomachs of slaughtered calves. The microbially produced chymosin 
product has been joined by microbially produced bST for enhanced milk pro-
ductivity that was approved by FDA in November, 1993 and marketed in Feb-
ruary, 1994, and by Flavr Savr™ tomatoes approved by FDA in May, 1994 
which are now also in the market. Clearly, momentum is growing for agricul-
tural biotechnology products and processes. Opponents of these products 
have had a losing year in their battle to keep agricultural biotechnology prod-
ucts either out of the marketplace or “dead on arrival” in the marketplace.
In this section I will provide synoptic tables of selected agricultural bio-
technology products and processes for food, crop production, energy, mate-
rials, and health care. The tables include a general description of the product 
or process, its status, its advantages and a listing of public good.
Food  Products  and  Processes
Four food or food safety products are summarized in Table 1: clotting enzyme 
for cheesemaking, bST for improved milk productivity, DNA-probe diagnos-
tics for food-based microbial contaminants and improved consumer prefer-
ence characteristics of fruits and vegetables, e.g., Flavr Savr™ tomato. All of 
the above products are already in the marketplace.
The public good benefits include the areas of economics, health and envi-
ronment. The favorable public perception of high-purity chymosin produced 
by transgenic bacterial systems versus the unfavorable perception of low-pu-
rity chymosin from slaughtered calf stomachs probably caused the opponents 
of agricultural biotechnology not to express opposition to this biotechnology 
product in the manner they expressed concern about bST also produced
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TABLE l: FOOD PRODUCTS AND PROCESSES
Clotting  Enzyme  for  
Cheesemaking
bST for  Improved  Milk  
Productivity
DNA-Probe  Diagnostics  
for  Food -Based  
Microbial  Contaminants
Improved  Consumer  
Preference  Characteristics  
of  Fruits  and  Vegetables
Technology
Transgenic microbes produce 
identical enzyme
Transgenic microbes produce a 
product essentially identical to 
bovine bST
DNA probes for Listeria, E. Coli, 
L. monocytogenes, Salmonella, 
Staphlococcus aureus, Campy­
lobacter and Yersinia enterocolitica
Antisense technology used to 
extend tomato shelf-life
Status
FDA approved chymosin 3/90; 
60% of market; Kosher, halal, 
vegetarian accepted
FDA approved Monsanto 
Prosilac™ 11/93; Marketed 2/94 
following 90-day moratorium; 
Used on 10-15% of cows by 4/94
GENETRAK Systems, Inc. 
markets kits
FDA approved Calgene Flavr 
Savr™ tomato 5/94
Advantages
50% cost reduction 
Reliable, reproducible supply; 
High purity; High cheese yield
10-15% increased production
Speed: 24-48 hours; Equal or 
better than traditional culture 
methods sensitivity/specificity
Increased shelf life; 
Improved flavor
Public  Good  
Economics Reduced cost; 
Reliable supply
Decreased cost of milk 
production; 
Lower cost to consumer
$40 billion cost/year Premium for value added
Environment Fewer cows-less methane and 
manure
Health High purity
Neutral overall: possibly 
increased milk consumption 
with lower cost; Requires above 
average farm management
Reduce the 80,000 illness 
(death in a few cases) per year
Increased fruit/vegetable 
consumption
Other
v_
Perception-microbial vs. 
slaughtered calf stomachs
Concern about impact on less 
efficient (not necessarily 
smaller) dairy farms
microbiologically. I suggest that the concern about the impact of bST on dairy 
farmers really is a concern for the survivability of less efficient dairy farms whose 
survival may not be an overall public good. However, lower cost of milk to the 
consumer, that should result ultimately from use of bST, is a public good. In 
general, improvements in agriculture ultimately benefit the consumer. Such 
improvements are the basis of the very low cost of food in the U.S. and Canada. 
Overall, agricultural biotechnology products now in the marketplace will impact 
in a highly positive manner on the public good. Improvements in the methods to 
detect microbial contaminants in food should decrease illnesses and even deaths 
such as occurred in the recent case of microbially contaminated ground beef. 
Reduction in the major estimated annual cost of $40 billion for time lost due to 
these illnesses could be major. Increased consumption of fruits and vegetables 
is being recommended for improved health. Products such as the Flavr Savr™ 
tomato should promote this desired dietary change.
The progress in development and marketing of food products and processes 
is impressive. Chymosin, the first transgenic food product, was approved by 
the FDA in early 1990. Four years later it has captured a 60% market share. Fur-
thermore, it is accepted as kosher, halal and vegetarian, thereby demonstrating 
the broad acceptability of a transgenic food material. It is expected that bST 
from transgenic organisms and Flavr Savr™ tomatoes, which were approved by 
FDA in 1994, will show similar acceptance within four years as that now achieved 
by chymosin. Within only two months of approval, bST was reported to be 
used on 10-15% of cows. All of the above food products and processes provide 
significant economic benefits and/or added value and health benefits to consum-
ers. The above should be viewed as the earliest examples of food biotechnology 
products and processes with substantial overall public good.
Crop  Production
Three examples of agricultural biotechnology products for crop production are 
summarized in Table 2. None is yet in the marketplace. Research and develop-
ment for transgenic crops with enhanced or added herbicide tolerance is highly 
advanced, and products should be marketed within the next few years. Cur-
rently, crops with herbicide tolerance produced by traditional selection and cell 
culture methods are marketed. Transgenic plants with coat-protein genes or 
other viral genes to protect against viruses are in advanced field-testing. For 
example, the improvement in quality and yield of squash produced by Asgrow is 
dramatic. A more futuristic potential is self nitrogen-fertilizing cereal grains 
that contain the legume genes for symbiotic nitrogen fixation. The potential 
public good benefits for this product are outstanding in multiple areas: replace-
ment of the $20+ billion annual cost for synthetic nitrogen fertilizer, decreased 
NOj(nitrates) in ground water and a sustainable method to replace fossil fuel 
based synthetic nitrogen fertilizer—all with applications in both developed and 
developing countries. Major research and development remains to be done. At 
the Boyce Thompson Institute, the biological materials to produce self nitro-
gen-fertilizing plants are in hand and the approach is defined. There is a reason-
able chance of success within the next fifteen years if the needed investment is 
made now.
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TABLE 2: CROP PRODUCTION PRODUCTS
Transgenic  Crops  with  Enhanced  
or  Added  Herbicide  Tolerance
Trangenic  Plants  with  Coat  and  
Other  Viral  Genes
Self -Nitrogen  Fertilizing  Cereals ^
T ECHNOLOGY
Tolerance genes for Bromoxynil, 
Glyphosate, Sulfonylureas, 
Imidazolinones and others
Virus-resistant fruit and vegetable 
crops: cucumber, squash, papaya, 
etc.
Transgenic cereals with legume genes 
for symbiotic nitrogen fixation
Status Many successful field trials; 
Bromoxynil cotton (Calgene, Inc.) 
deregulated status by USDA/APHIS
Field trials by Asgrow show major 
improvement in quality and yield of 
squash
Early research, but approach is defined 
and doable; 30+ single gene pea mutants 
for sytn genes generated and being 
located, isolated and characterized
Advantages Increased efficacy of and flexibility in 
weed control Quality and productivity
Public  Good  
Economics Reduced cost of weed control Reduced cost
Reduce $20 billion synethic nitrogen 
fertilizer cost with transgenic seed 
(corn, wheat, rice) and microbes
Environment
Enable use of more effective herbicides 
with less residue; Safer use of safer 
herbicides (see NABC Report 3); Reduce 
cultivation and soil erosion; Develop-
ment of herbicide-tolerant weeds is 
often expressed as concern.
Concern regarding viruses with 
expanded host range
Decreases in: NOj ground water 
pollution; greenhouse gases (N20, 
C02) and impact on global N cycle
Health
Reduced soil/water residues of 
long-lived herbicides
Increased consumption of fruits and 
vegetables due to reduced cost
Improved drinking water quality
Global
Interdependence
e.g., Papaya in Brazil Applicable to both developed and 
developing countries
Sustainability
V
Replace fossil use
E N E R G Y  P R O D U C T S
Two examples in the energy area are summarized in Table 3. Biodiesel, which 
is the methyl esters of plant or animal oils or fats, is being proposed as a 20 
percent component of diesel fuel. This 20 percent biodiesel fuel reduces sub-
stantially particulate emissions without the need for major capital costs in en-
gine or vehicle modification. The Environmental Protection Agency (EPA) is 
reviewing information to determine if 20 percent biodiesel in diesel fuel can 
be designated as substantially similar to diesel. With such a designation, this 
20 percent biodiesel product could be used without delay, which should en-
able public transport buses to reduce particulates in diesel exhaust for the 
January 1, 1995 requirements of the Clean Air Act. With required approvals, 
biodiesel could be a commercial product within the year providing multiple pub-
lic good benefits. Another energy example is oxygenated gasoline. Lignocellu- 
losics are an abundant part of agricultural wastes and forestry materials. Much 
research has focused on producing an economic process to produce ethanol for 
oxygenated fuels from these low-cost materials. About 30 percent of ligno- 
cellulosics is hemicellulose. A biotechnological process invented by the Uni-
versity of Florida is being developed by Bioenergy International for the highly 
efficient conversion of hemicellulosics to ethanol. Added value and reduced 
cost are the key benefits from this process. There are other energy products in 
the pipeline but space does not allow their review; the above examples 
should be viewed as illustrative.
T A B L E  3 :  E N E R G Y  P R O D U C T S
Biodiesel Oxygenated  Gasoline  ^
Technology Methyl esters of plant oils or 
animal fats, e.g., soydiesel
Hemicellulose to ethanol by 
transgenic microorganism
Status
20% biodiesel in diesel fuel re-
duces particulate emision with-
out engine/vehicle modification; 
Many tests in process with city 
buses and other; EPA reviewing 
regarding substantially similar 
designation
Process being developed by 
Bioenergy International
Advantages New use for plant oils with envi-
ronmental and economic benefits
Value added to waste material
Public  Good  
Economics
Reduce capital costs for retrofit 
but increase operating cost; Ex-
panded market for plants/oils
Added value/reduced cost
Environment
Reduce particulates in diesel 
exhaust to meet 1/1/95 require-
ment by Clean Air Act
Ethanol and clean air; 
Recycle carbon dioxide
Health Cleaner air Reduce air pollution
^ Sustainability Renewable vs. fossil Renewable vs. fossil ^
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HUMAN HEALTH CARE PRODUCTS
Therapeutics and vaccines are major human healthcare products. Transgenic 
animals with human genes are being developed to produce human therapeu-
tic proteins in milk or blood. Table 4 lists several that are in the experimental 
stage. The value-in-use per animal is very high, but the number of animals 
needed will be limited. Such therapeutic-manufacturing animals, though, 
may be very relevant for the production of drugs in developing countries since 
it is the transgen ic an imal itself that is the production facility. A longer-term 
agricultural biotechnology effort is the production of edible vaccines by trans-
genic fruits and vegetables. This program at Texas A&M University is in the 
early research stage. It is suggested that the cost of such edible vaccines could 
be as low as six cents per “vaccine” food. The public good to developed as well 
as developing countries would be major, to say nothing of the benefit to the 
vaccine consumer who no longer must endure an injection.
Materials
Materials, both organic and inorganic, are huge total-volume markets. Prior 
to the era of cheap and consistently available fossil materials, agricultural 
and forestry materials were the primary source of most of the carbon-based
TABLE 4: HEALTH CARE PRODUCTS
r~ Human  Proteins Oral  Vaccines  ^
Technology Transgenic animalswith human 
genes produce human proteins 
in milk/blood
Edible vaccines produced by 
transgenic fruits (bananas) 
or vegetables
Status All are experimental; tx-l-anti- 
trypsin to treat emphysema by 
sheep; tPA for early treatment of 
heart attack by goats; Protein C 
to keep blood from clotting by 
pigs; Hemoglobin as a substitute 
for red blood cells; Lactoferin, a 
mother’s milk protein for baby 
formulas by cows
Early research;
Transgenic plants produced 
Hepatitis B vaccine
Advantages Milk in most cases as the starting 
material for purification
Low cost and delivery in a 
normally consumed food
Public  Good  
Economics Very high value-in use animal 
products, e.g., $ 100,000/yr. animal
Low cost; 6 cents per 
“vaccine” fruit
Health Therapeutic or beneficial Immunization, especially for 
chi Idhood diarrheal diseases in 
developing countris
Global
Interdependence
May be very relevant to 
developing countries
Especially appropriate to 
children in developing 
countries but could also be 
used in developed countries^
materials. New technology and increasing concerns about the negative envi-
ronmental impacts of fossil-based materials is generating a reemphasis on ma-
terials from agricultural and forestry products (see Table 5). A high-value 
polyester called Biopol™, produced by bacteria, is being marketed by ZENECA, 
Inc. as a non-wettable paper coating and moldings for bottles. Transgenic 
plants are also being developed to produce this and other polymers; the poten-
tial is large, but the research is at an early stage.
Nature already provides large quantities of materials that are used exten-
sively. For example, worldwide cotton production in 1992 was about 19 billion 
kilograms (kg) out of a total worldwide fiber production of both synthetics and 
naturals of about 42 billion kilograms. An exciting example of a relatively un-
developed natural fiber is milkweed floss (Table 5). Natural Fibers in Nebraska 
has commercialized milkweed floss for the pillow and comforter market. They 
see potential for milkweed floss in nonwoven yarn and other markets. Successful 
utilization of milkweed floss fiber in these markets could lead to the domesti-
cated production of millions of acres of milkweed The possible economic ben-
efits in the materials area are huge.
The above examples illustrate the major public good that exists or is ex-
pected to flow from agricultural biotechnology products and processes. The 
breadth of the products and processes—from food to energy to materials to 
human health—is enormous. The potential is well beyond that recognized by 
the informed public, and even many scientists who probably think of agricul-
tural biotechnology as being relevant only to crop and animal production, or 
possibly to food. The diversity and strength of the public good for these agri-
cultural products and processes needs to be communicated. The next section 
discusses a government initiative to improve our success in delivering these 
products and processes to the public.
COMMERCIALIZATION OF
AGRICULTURAL BIOTECHNOLOGY PRODUCTS AND PROCESSES
For public good to occur, the products and processes generated by research and 
development, for the most part, must be commercialized. This critical step is 
the limiting factor for most areas of technology, and biotechnology is no ex-
ception. Some describe this limiting factor as the “valley of death” which 
dramatically communicates our failure, in too many cases, to convert science 
and technology to successful commercial products and processes. In recent 
years the U.S. government increasingly has recognized the importance of im-
proving our success in crossing the “valley of death” and has generated some 
initiatives to facilitate technology development and precommercialization 
activities. Two government initiatives have been established recently: one is 
the Alternative Agricultural Research and Commercialization (AARC) agency 
in the U.S. Department of Agriculture (USDA) and the other is the Advanced 
Technology Program (ATP) in the National Institute of Standards and Tech-
nology (NIST) in the Department of Commerce.
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TABLE 5: MATERIALS
Biopolymers  by  Microbes
Phytopolymers  by  Transgenic  
Plants
Natural  Phytopolymers /Fibers
Technology
Transgenic plants to produce polymers/fi- 
bers with functionality that meets or exceeds 
that produced by synthetic chemistry; 
Opportunities for polyesters, cellulosics 
and amides
Milkweed floss for down, non-woven yarn 
and other markets
Status
Biopol™1 is produced and marketed by 
ZENECA, Inc. as non-wettable paper coating 
($15/lb) and molding for bottles for high value 
products (cosmetics and shampoos) ($8/lb); 
ProNectin™byProteinPolymerTechnologies; 
Cellulon™ by Weyerhauser Company
Early research; Polyester synthesis by trans-
genic A r a b id o p s i s  and Canola (0.1%)
Methods and equipment developed by 
Natural Fibers to grow, harvest and pro-
cess milkweed with production of 
comfortors and pillows marketed as 
Ogalala Down™;
Cultivar improvement
Advantages
Biodegradable but processing cost high Yet to be demonstrated; Infinite variations 
with designed genetic template; Solar energy
Opportunity for major new crop with 
substantial value-in-use
Public  Good  
Economics
Reduces disposal cost of non-biodegradable 
polymers
High performance?; 
Lower cost?; 
Domestic production
Major potential for agriculture; Very high 
to good value-in-use; Potential major 
new crop: reduces need for subsidies and 
offers rural opportunies; Jobs; 
Domestic vs. imported materials
Environment Biodegradable Renewable vs. fossil; Biodegradable; 
Decentralized manufacture
Perennial crop; Low water and nitrogen use; 
Opportunity for additional crop rotation
Health Hypoallergenic vs. goose down
Sustainability
V
Renewable source Renewable Renewable
1 Biopol™ polyester copolymer of (3-Hydroxy Valerate and Butyrate
a. Ui
Ui
AARC was created in the 1990 Farm Bill. Its two major proponents were 
the former Secretary of Agriculture and the New Uses Council. The role of 
AARC is to provide risk investment to the private sector for support of pre-
commercialization activities for new added-value, non-food and non-feed 
uses of agricultural and forestry materials. The private sector must provide at 
least a 1:1 dollar match for the funds provided by AARC. AARC’s primary ob-
jective is to utilize the excess U.S. agricultural production capacity or U.S. sur-
pluses of agricultural and forestry materials for industrial products for domes-
tic and international markets and to reduce simultaneously and substantially 
the need for agricultural subsidies. There are other expected benefits from 
AARC investments of public funds. Overall economic development should 
occur within the agricultural and forestry sectors. Production, processing 
and distribution of these added-value industrial products will create, for the 
most part, jobs in rural areas since the bulky raw materials are located in rural 
areas and are expected to be processed near their origin.
I am one of the nine members of the original AARC Board appointed in 
1992. Based on my experience on other national committees, boards and com-
missions, the commitment and enthusiasm of the AARC Board members to the 
AARC mission is unprecedented. The Board believes that AARC is the right 
thing to do and that government has set it up the right way. These industrial 
products from agricultural and forestry materials should expand the use of 
renewables and reduce fossil use. The environmental impact from the bio-based 
industrial products should be reduced relative to those based on fossil sources. 
Also, the bio-based system should be more sustainable.
The operation of AARC is unique and may represent a model for manage-
ment of future government investments in development. The AARC board is 
appointed by the Secretary of Agriculture with input from the National Science 
Foundation (NSF) and the Department of Commerce. The Board is composed 
of nine members with eight from outside of government representing techni-
cal, business and entrepreneurial expertise. This Board is not an advisory com-
mittee but rather an operating board that has total responsibility for the opera-
tion of AARC and reports directly to the Secretary of Agriculture. The Board 
operates AARC as a business, not as a government grant program. The Secre-
tary of Agriculture can override decisions of the Board but must do this in 
writing. To manage investments in development, AARC utilizes the experi-
ence mainly of entrepreneurs from the private sector rather than government 
bureaucrats. There are five presidents or vice presidents of private corpora-
tions on the original Board.
The composition and experience of the AARC Board is one of the keys to 
the novel operating structure of AARC. The other major key is the financial 
management of AARC investments. The government funds allocated to AARC 
are placed in a revolving fund. AARC investments are made so that the AARC 
revolving fund will receive a return on its investment based on the financial
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success of the products or businesses. This return may come from equity, roy-
alties or other appropriate methods negotiated at the time of the AARC invest-
ment. It is the goal of AARC that the revolving fund will become financially 
self-sustaining, maybe within ten years. Society talks about sustainability in 
many areas. Why should government programs not be set up to be sustain-
able? The taxpayer provides the key start-up funds, but the activity must be-
come self-sustaining if it is to continue. Thus the taxpayer will not need to 
provide continuous financial input. AARC aims to bring self-sustainability to 
a government program.
AARC seeks and evaluates proposals through broad solicitation and in- 
depth competitive reviews. There is external review by technical and business 
experts. The Board uses these external reviews and its own evaluation to select 
the most promising preproposals to be submitted as full proposals. Prior to 
funding, at least one Board member visits the site to meet with management, 
review the plan and facilities, and negotiate the basis for financial return to 
the AARC revolving fund. Board members and staff monitor the businesses on 
a regular basis. AARC has made investments in at least three of the examples 
described above.
The major limitation of AARC at this stage is the level of funding. Annual 
funding of less than $10 million enables AARC to invest in only a fraction of 
the promising opportunities. The U.S. must continue to fund and substan-
tially expand our funding of research for new uses of agricultural and forestry 
materials. Even more importantly, the U.S. must increase substantially the 
investment in precommercialization activities. Such investments will serve the 
public good through new jobs, rural development, reduced subsidies and a 
self-sustaining investment fund for businesses based on agricultural and for-
estry materials.
Another government initiative to facilitate technology transfer across 
the “valley of death” is the Advanced Technology Program (ATP). Its objec-
tive is economic development by improving the competitiveness of U.S. in-
dustry with new high-value products/processes/services for domestic and in-
ternational markets. It, like AARC, also hopes to create jobs. ATP focuses 
mainly on the urban non-agricultural area with investments in, for example, 
the electronics industry. The goals of AARC and ATP are similar, although 
the former is focused, for the most part, on rural communities and expanding 
the opportunities for agricultural and forestry materials. The operation of 
the AARC and ATP are very different. ATP operates as a traditional govern-
ment program with management by government bureaucrats and no require-
ment for a return to the program from successful investments. ATP identifies 
technology or product deliverables, as does AARC, but does not seek a finan-
cial return so as to become self-sustaining. I believe that the AARC style of op-
eration with decisions made by experienced, private-sector entrepreneurs and 
with a financial return to enable sustainability is a step in the right direction
and consistent with the proposal of the current administration to reinvent gov-
ernment. ATP is growing at 80+ percent per year based on government funding 
and will shortly have 50+ times the annual funding provided to AARC. Both 
are excellent, timely programs. AARC needs to grow in the way ATP is grow-
ing so that AARC has funding consistent with the level of biobased opportu-
nities, estimated to be at least ten percent as compared to ATP, not one to two 
percent as reflected in current funding. Both ATP and AARC can be impor-
tant to the public good.
IN SUMMARY
A hierarchical structure of public good based on relative importance is pre-
sented. The issues, arranged starting with the greatest to level of importance, 
are: freedom of choice, knowledge, human health, economics, environment, 
sustainability, global interdependence and other. The other public good cate-
gory includes issues that apply only to limited subsets of people. Fourteen se-
lected examples of current and next generation agricultural biotechnology 
products and processes, crop production products, energy products, health-
care products, and materials were presented. A brief statement of technology 
status and advantages for each example is presented as well as the identifica-
tion of public good for the relevant issues such as economics, health, environ-
ment and sustainability. The selected examples range from a transgenic prod-
uct for cheese making, initially marketed in 1990 and presently with a domi-
nant market share, to now marketed and much debated bST and Flavr Savr™ 
tomato products and processes in development such as biopolymers and a pro-
cess for ethanol production for oxygenated fuels to products in the very early 
research stages such as self nitrogen-fertilizing cereals and edible plant vac-
cines for humans. Major public good exists or is expected for the above prod-
ucts or processes that are in the market, in the development stage, or in the 
research stage.
Public good requires the transfer of technology from the research and de-
velopment arena to products and processes in the marketplace. Without com-
mercialization or equivalent delivery to the users, there is no public good. A 
new federal program, the Alternative Agricultural Research and Commercial-
ization Center, located within USDA, is described. Its mission is to invest in 
commercialization by the private sector so as to facilitate the marketing of new 
industrial (non-food or non-feed) value-added products from agricultural 
and forestry materials.
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